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FluorescenceTBsmr is a secondary active multidrug transporter fromMycobacterium tuberculosis that transports a plethora
of compounds including antibiotics and ﬂuorescent dyes. It belongs to the small multidrug resistance (SMR)
superfamily and is structurally and functionally related to E. coli EmrE. Of particular importance is the link be-
tween protein function, oligomeric state and lipid composition. By freeze fracture EM, we found three differ-
ent size distributions in three different lipid environments for TBsmr indicating different oligomeric states.
The link of these states with protein activity has been probed by ﬂuorescence spectroscopy revealing signif-
icant differences. The drug binding site has been probed further by 19F-MAS NMR through chemical labeling
of native cysteine residues showing a water accessible environment in agreement with the alternating access
model.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The secondary multidrug/proton antiporter M. tuberculosis TBsmr
(previously mmr (Rv3065)) from the SMR superfamily consists of 107
amino acids and has a sequence homology to E. coli EmrE of about
43%. EmrE forms four transmembrane helices [1–5], thus constituting
the smallest known multidrug transporter [6]. The sequences of SMR
proteins are predominantly hydrophobic with few polar residues. A
glutamic acid in helix 1 (E13 in TBsmr, E14 in EmrE) is the only
membrane-embedded charged residue. It is highly conserved among
all studied SMR proteins [7] andwas shown to be essential for SMR pro-
tein activity [8,9]. SMR proteins are active as dimers consisting of two
four-helix bundles [5,10], while their orientation is still being discussed
[11,12]. Low resolution cryo-EM [13] and X-ray [14] as well as recent
NMR data [15] have been obtained for EmrE and show an antiparallel
structure. However, the oligomeric form in vivo is not conclusively de-
termined and could very well be tetrameric [16–18].
SMR proteins transport a variety of hydrophobic substrates including
antibiotics and ﬂuorescent dyes [19,20]. TBsmr is one of the transporters
conveying multidrug resistance to M. tuberculosis [21], which belongs
to the clinically most challenging MDR organisms [22]. Drug transportmistry, J. W. Goethe University,
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rights reserved.might occur by an alternating access model [23,24] similar to what has
been proposed for secondary active importers such as LacY or LeuT
[25,26]. A ﬂuorescence study on TBsmr [8] demonstrated an occluded
ethidium bound state (also found in EmrE [27,28]) in agreement with
the alternating access transport hypothesis according towhich the protein
undergoes exchange between different conformational states [4,15,29].
Typically, transport activities were determined in E. coli lipids while
in DMPC, binding afﬁnities have been measured. A comparative study
on EmrE and TBsmr examined the transport rate for methylviologen
as a function of the lipid headgroup composition [30,31].
Here, we probe the oligomerization state of TBsmr in different lipid
preparations by freeze fracture electron microscopy (FF-EM). The
protein's capability to bind substrate and to form an occluded state dur-
ing transport in these preparations was probed by observing ﬂuores-
cence quantum yield and anisotropy changes of the substrate ethidium.
Solvent accessibility was probed by 19FMAS NMR on a transport compe-
tent state. Both EM and solid state NMR are perfectly equipped to inves-
tigate membrane proteins in their native environment, the lipid bilayer.
2. Materials and methods
2.1. Materials
All chemicalswere purchased fromApplichem (Darmstadt, Germany)
unless indicated otherwise. Lipids were purchased from Avanti Polar
Lipids (Alabaster, AL, USA).
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Wild-type TBsmr with Myc-His Tag in pT7-7 was kindly provided
by S. Schuldiner, Hebrew University of Jerusalem. The single site mu-
tations were introduced by site-directed mutagenesis (Stratagene,
Amsterdam, Netherlands) with the following forward and reverse
primer, respectively: TBsmr W30A 5′-GGT TCA CTC GGT TGG CGC
CCA CGG TGG-3′, 5′-CCA CCG TGG GCG CCA ACC GAG TGA ACC-3′.
TBsmr W30A C35S 5′-GGC CCA CGG TGG GCT CTC TAG TGG GTT
ATG GC-3′, 5′-GCC ATA ACC CAC TAG AGA GCC CAC CGT GGG CC-3′,
TBsmr W30A C8S C35S (TBsmr W30A ΔCys) 5′-CCT ATA CCT CTT
GTC CGC GAT CTT CGC GG-3′, 5′-CCG CGA AGA TCG CGG ACA AGA
GGT ATA GG-3′.2.3. Expression, puriﬁcation, reconstitution
TBsmr was expressed and puriﬁed as described previously [8].
Reconstitution of TBsmr was done by mixing the eluted protein
with lipid solubilized in DDM. For removal of detergent the protein
solution was incubated o/n at room temperature with Bio-Beads
(Carl Roth GmbH, Karlsruhe, Germany).2.4. Fluorescence measurements
For theﬂuorescencemeasurements TBsmrwas reconstituted in E. coli,
DMPC and POPC lipids at a ratio of 400:1 mol/mol (The lipid to protein
ratiowas estimated to be between100:1 and300:1 for the freeze fracture
images.). Transport of ethidium was measured via a coupled transport
assay. In short: Bio-Beads were removed after reconstitution and
proteoliposomes were fused with purple membrane patches containing
bacteriorhodopsin (bR) isolated from Halobacterium salinarium. BR and
ethidium are excited simultaneously at 545 nm via a Jasco FP-6500 ﬂuo-
rescence spectrometer (Jasco, Groß-Umstadt, Germany). Temperatures
were kept constant at 25 °C using a thermostatic circulating water bath
(Thermoﬁsher, Schwerte, Germany).While bR establishes a proton gradi-
ent, TBsmr starts transporting ethidium across themembrane. The trans-
port results in a ﬂuorescence increase, which is recorded. To collapse the
proton gradient 1 μM CCCP are added to the sample solution. A detailed
description of the assay is given in [8,32].
Steady state ﬂuorescence anisotropy was measured with the
ethidium concentration (2 μM) kept constant, and analyzed using
Origin 8.5 (OriginLab Corporation, Northampton, MA, USA) using a
single site binding model.
Leakage of protons across the bilayer was tested using 1 μM
8-Hydroxypyrene-1,3,6-trisulfonic acid, trisodium salt (HPTS). HPTS
was incorporated into liposomes by freeze thawing and subsequent
dialyzing at pH 7 over night at 4 °C. The HPTS containing liposomes
were added to a buffer of pH 9.4 and the ﬂuorescence change was
recorded via a Jasco FP-6500 ﬂuorescence spectrometer (Jasco,
Groß-Umstadt, Germany).2.5. Freeze fracture electron microscopy
Proteoliposomes with a lipid to protein ratio of 75:1 mol/mol
(E. coli and DMPC) or 50:1 (POPC) in sample holders were frozen in
ethane cooled to −180 °C by liquid nitrogen. Fracturing at −120 °C
and replication at a shadowing angle of 45° with platinum/carbon
was performed with a BAF 060 freeze-fracturing unit from Bal-Tec
Inc. (Principality of Lichtenstein). The fracture images were enlarged
from a ×16k to ×25k primary magniﬁcation to a ﬁnal magniﬁcation
of ×116,800 to ×194,500 and digitized (1024×1024 pixels). Images
were analyzed by measuring the diameters of the protein particles
perpendicular to the direction of shadowing (Fig. S1).2.6. Simulation of particle size distributions
Theoretical particle size distribution functions were calculated for
four different oligomeric states of TBsmr, which were approximated
by different ellipsoids (Fig. 2, Fig. S4). Their dimensions were estimat-
ed from EmrE 2D crystal data (PDB: 2I68) [33]. The protein particles
are randomly oriented within the membrane plane and with respect
to the direction of shadowing resulting in a distribution function,
which depends on the particle's size and shape. The shape of the ob-
served distribution function is also affected by measurement errors
due to limited resolution, which is approximated by a Gaussian distri-
bution. Theoretical distribution functions were calculated for 200.000
random orientations and plotted as histograms (Fig. 2). Different
standard deviations and bin sizes were used. Simulations were car-
ried using Mathematica 7.0 (Wolfram Research). Further details are
provided as supplementary material (Fig. S4).
2.7. 19F solid state NMR spectroscopy
TBsmr wt and mutants were labeled with 3-Bromo-1,1,1-
triﬂuoroacetone (BTFA) as described previously [34]. All spectra
were acquired on a Bruker Avance 600 (600.13 MHz for 1H and
564.69 for 19F) using a 4 mmMAS DVT probehead (Bruker, Karlsruhe,
Germany) at 275 K and 10 kHz MAS frequency. Chemical shift was
referenced to Triﬂuoroacetic acid at 0 ppm. A typical 90° pulse was
4 μs with 60 kHz proton decoupling. Topspin (Bruker, Karlsruhe,
Germany) were used for data acquisition and processing. Line broad-
ening used for processing was 25 Hz. BTFA chemical shift calibration
was carried out by solving BTFA in various water-free organic sol-
vents. Dielectric constants were taken from the Bruker Almanac
[35]. The observed chemical shifts could be described empirically
by a monoexponential function δ=Aexp−ε /ε0+y (Eq. (1)).
3. Results
TBsmr was heterologously expressed in E. coli, puriﬁed, solubilized
and reconstituted in DMPC, POPC and E. coli lipids. The choice of these
lipids was mainly determined by the achieved reconstitution efﬁcien-
cy. TBsmr in these sample preparations has been analyzed in terms of
its oligomeric state and its activity as outlined below.
3.1. Oligomeric state of TBsmr
The resulting proteoliposomes were analyzed by freeze–fracture
electron microscopy. Protein particles can be observed as elevations
within the proteoliposome images. In all three cases, a homogeneous
protein distribution with no aggregates but different particle sizes is
observed (Fig. 1a).
In order to quantify particle diameters, a statistical analysis had to
be carried out. For freeze fracture EM the proteoliposomes are frozen
(cryoﬁxed) and then split along the bilayer interface by fracturing.
This results in half membranes with protruding proteins (particles).
By unidirectional shadowingwith platinum–carbon, a replica is formed,
which is observed by electronmicroscopy. The diameter of the particles
was measured perpendicular to the direction of shadowing (Fig. S1).
The platinum–carbon coat was subtracted (3.8 nm) from the obtained
values [36]. The resulting particle size distributions were plotted as
frequency histograms [37]. A resolution of up to ±0.5 nm has been de-
termined for freeze fracturemicrographs of gold particles [38] but a bin
size of 0.8–1.0 nm was necessary here in order to smooth gaps in the
histogram caused by the width of individual pixels in the digitized
images. The resulting particle size distributions shown in Fig. 1b reveal
mean distances and distribution widths of TBsmr particles of approx.
3.5 and 2 nm for DMPC, 5 and 4 nm for POPC and 5.5 and 6 nm for
E. coli lipids.
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Fig. 1. (a) For each lipid an example freeze fracture electron microscopy image of reconstituted TBsmr is shown. A homogeneous distribution of the protein throughout the
proteoliposomes is observed. (b) The distribution of particle diameters differs between all samples. The obtained particle size distributions are compared to those expected for a
monomer, a dimer, a side-to-side tetramer and an end-to-end tetramer model (see Fig. 2). Between 100 and 300 particles were analyzed for each sample (0.8–1 nm bin size).
The DMPC data can also be described by a superposition of monomer–dimer distribution functions indicating the existence of mixed populations.
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brane protein can be estimated from its freeze fracture particle diam-
eter [38]. We have therefore calculated particle size distributions,
which would be expected for four different models. These models
are based on the EM structure of EmrE (PDB: 2I68) [33] and biochem-
ical data [5,18]. The size of a TBsmr dimer was estimated to be 3.1±
0.1×4±0.1 nm. The possibility of a monomer and dimers of dimers
was also included in the simulations. Possible arrangements of the
tetramer are a side-to-side orientation with ∼6.2×4 nm, as seen in
the crystallographic tetramers of the EM structure [33], or an end-
to-end tetramer (3.1×8 nm), based on the assumption that the olig-
omerization takes place at helix 4 [5,18]. Simulation results in Fig. 2 re-
veal a very broad distance distribution for an end-to-end tetramer but
more narrow distributions functions for monomer, dimer and side-to-
side tetramer. The latter distributions overlap signiﬁcantly, but the
dimer model shows a more narrow distribution with a smaller mean
diameter. As expected, the monomer shows the smallest mean diam-
eter, but its distribution width is comparable to the dimer model.
The calculated distribution functions and the experimental data
are shown in Fig. 1b. Particle diameters and their distribution widths
increase from DMPC to POPC and E. coli lipids. The experimentally ob-
served particle size distribution in DMPC is not compatible with ei-
ther tetrameric model and the center of the distribution is smaller
than expected for a dimer but larger than expected for a monomer.
In POPC, a particle size distribution comparable to dimer or side-to-
side tetramer is observed. In E. coli lipids, a broad distribution is
obtained. The overall shape of the distance distribution function can
be reproduced by an end-to-end tetramer, but the high abundance
of particles with larger diameters also indicates fractions of larger
oligomers. The deviations of the experimental data from the assumed
models are probably caused by the fact that the sample containsmixtures of monomers, dimers, both types of tetramers and higher
oligomers. This is especially evident for the DMPC data, which can
be also described by a superposition of monomer and dimer distribu-
tion functions (Fig. 1b, S5). Furthermore, the simulated particle size
distributions are based on a simpliﬁed model and the limited number
of particles detected could also restrict the experimental analysis.
3.2. Activity of reconstituted TBsmr
In order to test whether the oligomeric state observed in different
lipid preparations correlates with transport activity of TBsmr, a ﬂuo-
rescence ethidium bromide (EtBr) assay as described in detail by
Basting et al. [8] was carried out. Ethidium has been shown to be a
substrate of multidrug transporters including EmrE and TBsmr
[8,20,32,39]. In this assay, the proteoliposomes with reconstituted
TBsmr are fused with purple membrane patches containing the pro-
ton pump bacteriorhodopsin (bR) [8,32]. Using a wavelength of
545 nm, bR and ethidium are excited simultaneously. bR starts
pumping protons and builds up a proton gradient across the mem-
brane, which is needed to drive substrate translocation. It was
shown for EmrE and TBsmr that an occluded ethidium–protein com-
plex is transiently formed in the presence of proton motif force [8,28].
In this situation, ethidium is excluded fromwater resulting in a signif-
icant increase of its ﬂuorescence quantum yield observable at
610 nm. This unique possibility to observe a transient protein–
substrate complex serves to assay activity of TBsmr.
It clearly can be observed that TBsmr is transport active in E. coli lipids
as well as in POPC. Addition of carbonyl cyanide m-chlorophenyl
hydrazone (CCCP), which uncouples the proton gradient, fully abolishes
the formation of the ﬂuorescent transport intermediate state. In DMPC,
TBsmr displays no transport activity (Fig. 3a). The stability of the
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Fig. 2. Four theoretical particle size distributions were calculated assuming a TBsmr
monomer (a), dimer (b), end-to-end tetramer (c) and side-to-side tetramer (d). The
monomer and dimer shape was based on the EmrE crystal structure [33]. Histograms
of 200,000 simulated elliptic particles with corresponding diameters (4.0×3.1 nm,
4.0×6.2 nm, 8.0×3.1 nm, respectively) with an allowed standard deviation of 1 nm
per measurement were simulated. These simulations yield histograms (0.1 nm bin
size) with a characteristic shape and width from which the oligomeric state of the par-
ticles can be estimated (see also Fig. S4). The side-to-side tetramer model was included
for completeness but is less likely since such an inter-protein interface would lead to
uncontrolled oligomerization [46].
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the pH sensitive dye HPTS trapped within the liposomes (Fig. S6a). In
contrast to transport activity, equilibrium dissociation constants of
ethidium, as determined by ﬂuorescence anisotropy measurements,display similar values of about 1 μM for the three different lipid environ-
ments (Fig. 3b).
3.3. Probing the drug binding site of TBsmr
How substrates access the binding pocket of membrane proteins is
difﬁcult to answer generally. For EmrE it has been proposed that sub-
strates can enter via the membrane and via a water ﬁlled pore [10].
Recent EPR data indicate water accessibility in proximity to the sub-
strate binding site [40]. Our FF-EM data show that reconstitution of
TBsmr in DMPC results in smaller particle sizes than in POPC and in
E. coli lipids, while no transport activity is observed in DMPC. Particle
size distributions are more homogeneous in POPC samples than in
E. coli lipids. We have therefore probed the solvent accessibility of
the drug binding site in TBsmr within POPC liposomes using 19F
solid state NMR. Our approach utilizes chemical labeling of accessible
cysteines with 3-Bromo-1,1,1-triﬂuoroacetone (BTFA) attaching a
triﬂuoromethyl group to the cysteine side-chain as described previ-
ously [34]. TBsmr contains two native cysteins C8 and C35 (Fig. S3).
Residue C8 is in close proximity to the conserved residue E13 and
could be utilized to probe the solvent accessibility of the drug binding
pocket of TBsmr. 19F chemical shifts of BTFA have been calibrated
with respect to solvent polarity (Fig. 4b). To assign 19F resonances,
C35S and C8S/C35S mutations were introduced.
We found that expression yields were more consistent in our
hands when an additional W30A mutation was introduced. TBsmr
contains two tryptophan residues, W30 and W63, in its native se-
quence (Fig. S3). Only W63 is conserved in SMR proteins and relevant
for drug transport [41]. Fluorescence transport and anisotropy mea-
surements were carried out for all mutants TBsmr W30A, TBsmr
W30A C35S and TBsmr W30A ΔCys and compared to wild-type
TBsmr (Fig. S6b, S6c). Neither substrate binding nor transport was
signiﬁcantly affected by these mutations. This is not surprising be-
cause it has been shown for its homolog EmrE that mutations of
most residues, including its native cysteines, do not impair transport
ability [40,42,43].
TBsmr W30A and TBsmr W30A C35S were BTFA labeled and
reconstituted into POPC liposomes. For both mutants, a broad 19F res-
onance at a chemical shift of around−6 ppm was observed (Fig. 4a),
while for TBsmr W30A, a second narrow signal at −4.9 ppm is
detected. The resonances were ﬁtted via a mixed Gauss–Lorentz line
shape resulting in a peak ratio of approx. 20:1. As a control BTFA la-
beling was also applied to TBsmr W30A ΔCys resulting in no
detectible NMR signal verifying speciﬁc labeling of accessible cyste-
ines. It can therefore be concluded that the resonance at −6 ppm
stems from labeled C8. The resonance observed at −4.9 ppm could
originate from C35, but residual amounts of free label associated
with the membrane could also contribute to this signal. We therefore
restrict our data interpretation to C8. The BTFA chemical shift can be
interpreted in terms of environmental polarity (Fig. 4b, Table S1). The
19F chemical shift of C8 corresponds to a dielectricity constant close to
water, which is in agreement with high water accessibility explaining
the good labeling efﬁciency.
4. Discussion
Membrane protein function and structure are inﬂuenced by their
respective lipid environment (e.g. [44]). Successful reconstitution,
folding, the correct oligomerization state and activity of a membrane
protein depend on the lipid composition of the bilayer it is inserted
into. Here, we study the lipid dependent complex size of the MDR
transporter TBsmr and correlate this with its transport activity and
substrate binding capability. Furthermore, we can show that residues
in the binding pocket of TBsmr are accessible to water, which is in
agreement with current structural models [10,40].
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Fig. 3. (a) Transport of ethidium by TBsmr in DMPC, POPC and E. coli lipids has been assayed by ﬂuorescence spectroscopy. The quantum yield of ethidium increases due to the
formation of an occluded transport cycle intermediate state [8]. A stable transmembrane pH gradient is generated through illumination of TBsmr proteoliposomes fused with purple
membrane patches. The relative activity of TBsmr is of the same magnitude in E. coli lipids and POPC. For TBsmr in DMPC no transport activity is observed. After addition of 1 μM
CCCP, which collapses the ΔpH and ΔΨ, ethidium transport by TBsmr in all lipids is abolished. All measurements were carried out at a lipid to protein ratio of 400:1 (mol/mol).
(b) Fluorescence anisotropy of ethidium in the presence of TBsmr DMPC, POPC and E. coli lipids was measured under equilibrium conditions, i.e. without a transmembrane pH gra-
dient. The binding afﬁnity of ethidium to TBsmr is around 1 μM in all three cases.
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butions in different lipid environments (Fig. 1). In order to interpret
our experimental data, we have calculated theoretical distributions
for three oligomeric basic models (Fig. 2). The expected size distribu-
tion of the end-to-end tetramer model can be clearly distinguished
from the dimer and the side-to-side tetramer. The latter two are
less well distinguishable, but the dimer model shows a more narrow
distribution with a smaller mean diameter. The experimentally ob-
served particle size distribution in DMPC is not compatible with
both tetrameric models but the center of the distribution is smaller
than expected for a dimer and larger than a monomer. One possible(a)
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Fig. 4. (a) 19F solid state NMR on BTFA labeled TBsmr mutants reconstituted in POPC. TBsm
broad resonance at −6 ppm and a smaller narrow peak at −4.9 ppm. In TBsmr W30A C35
control, a cysteine free mutant TBsmrW30A C8S C35S was generated and subjected to the BT
of environmental polarity onto the 19F chemical shifts has been investigated by dissolving BT
to 80 [35]. The chemical shift values can be described empirically as a function of ε by an expo
BTFA labeled residues in terms of water accessibility.reason could be a mixture between monomer and dimer populations
(Fig. S4).
There is convincing evidence for dimer formation, e.g. from 2D
crystallization in DMPC [33]. Such an end-to-end dimer would also
agree well with crosslinking data on EmrE [16,45] and studies on
the homolog SMR protein Hsmr [18], which show that transmem-
brane helix four is important for protein–protein interactions. Such
interactions could drive the formation of dimers and end-to-end tet-
ramers. These studies were carried out in E. coli lipids in which we
have indeed observed particle size distributions compatible with a
large fraction of end-to-end tetramers. The size distribution in POPCToluene d8
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S, only C8 can be labeled showing again a broad resonance at −6 ppm (middle). As a
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FA in various organic solvents with different dielectric constants εwithin the range of 2
nential equation, allowing interpretation of experimentally observed chemical shifts of
566 K. Mörs et al. / Biochimica et Biophysica Acta 1828 (2013) 561–567agrees with both dimer and side-to-side tetramer models. Both cases
cannot be discriminated from each other within the resolution of the
method and it is feasible that in POPC and E. coli lipids, TBsmr exists as
mixture of dimers and higher oligomers. Nevertheless, a tetramerization
interface involving all transmembrane helices and not just helix 4 could
lead to uncontrolled oligomerization in the form of side-to-side tetra-
mers [46] and is therefore unlikely (Fig. 2d).
The question arises whether protein activity is correlated with the
observed particle size distribution. Indeed, we found that transport
but not the binding properties of TBsmr seem to depend on the
lipid environment. Unfortunately, substrate binding alone does not
offer a strong criterion to assess a functional oligomeric state of an
SMR protein. In case of EmrE for example, the Kd of ethidium was
found to be similar for monomeric and dimeric preparations [47,48].
The observed Kd for ethidium binding to TBsmr is almost identical
in all three lipid environments. This indicates similar binding pocket
properties but no correlation between substrate binding and observ-
able particle size distribution. In contrast to binding, ethidium trans-
port clearly depends on the lipid environment and/or the observed
particle size distribution. In both POPC and E. coli lipids, transport
has been observed while TBsmr in DMPC did not show any transport
capabilities. The lipid dependent activity of TBsmr could be either
caused by a modulation of TBsmr's conformational equilibriums in-
duced by bilayer properties or by speciﬁc protein–lipid interactions.
It has been shown before that TBsmr transport activity varies in
different lipid mixtures by systematically varying their headgroups
while keeping the chain lengths constant [31] but no data about the
oligomeric state of TBsmr in these preparations exist. Our study sug-
gests a link between lipid environment, complex formation and activ-
ity. Since time-consuming optimization of reconstitution conditions
for FF-EM did not allow an extensive screen, we can only offer some
educated guesses about the reasons for the observations reported
here.
Both DMPC and POPC contain the same quaternary ammonium
headgroup but vary in chain length and alkyl chain saturation (14:0
for DMPC, 16:0–18:1 for POPC). Variations of the alkyl chain length
and of the degree of saturation modify thickness, order and lateral
pressure proﬁle of the membrane. It was for example reported that
EmrE and TBsmr show decreasing transport activities with altered
lateral pressure proﬁles [30,31], while Yeagle and colleagues demon-
strated that transmembrane helix one of LacY alters its structural
properties when presented with a hydrophobic mismatch [49]. Due
to the shorter chain length of DMPC compared to POPC, such a
mismatch might also occur for TBsmr and the resulting shift in its
conformational equilibria might cause the protein's transport inac-
tivity. This interpretation is also supported by our experiments in
E. coli lipids: most lipid chains in E. coli membranes are in the
range of 16 to 18 carbon atoms either without or with one double
bond [50]. Why the observed particle size tends to be larger in
E. coli lipids compared to POPC cannot be explained directly from
our data. Both membranes differ in bilayer thickness, order and dy-
namics [51], which might modulate the conformational equilibri-
ums of TBsmr in such a way that the formation of higher oligomers
is promoted in E. coli while structural factors needed for transport
are unaffected.
Our 19F-MAS NMR data show that residue C8 is solvent exposed.
C8 is located in helix 1 close to the highly conserved and functionally
essential residue E13, which is responsible for drug binding and
transport (Fig. S3). The observed water accessibility indicates a
water accessible drug binding site in TBsmr reconstituted in POPC.
This would be in agreement with the alternating access model as pro-
posed previously [40,43,52]. This also correlates with recent EPR data
on EmrE reconstituted in apolectin that show water accessibility
along helix one and two [40]. Furthermore, cryo-EM data show that
the EmrE drug binding pocket is accessible laterally from the bilayer
and also via a water ﬁlled pore [10].5. Conclusions
In summary, we ﬁnd a correlation between TBsmr oligomerization
and activity while a link between oligomerization and lipid environ-
ment seem to exist. In support of an alternating access model, we
found water accessibility of residues close to the assumed drug
binding/oligomerization interface. Further studies will include drug
and pH titrations as well as a more comprehensive study of the effect
of acyl chain length, headgroup and degree of saturation to investi-
gate the oligomeric state and the drug/proton translocation pathway
in more detail.
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